The move is aimed at preventing antimicrobial resistance (AMR) triggered by overuse and misuse of antibiotics. The regulator has been banning several fixed dose combinations of drugs or cocktail medicines which have proven to be irrational and harmful. Majority of these drugs are being approved by state regulators
